 2006 Conference
Health Care
 programs at Wharton
2004 Conference
|
Panelists: Entrepreneurship Panel
Joseph W. Kaufmann
President and Chief Executive Officer
Kensey Nash Corporation
Mr. Kaufmann has served as Chief Executive Officer and President of the Company since March 1995. Mr. Kaufmann joined the Company in 1989 as Chief Financial Officer and Secretary. He has been a Director since September 1992. He was appointed Vice President, Finance and Administration in January 1994. From 1987-1989 Mr. Kaufmann was controller for a division of Hanson, PLC. and from 1978-1986 he was employed by a division of Syntex as a Senior Financial Executive. Mr. Kaufmann has a B.S. degree from St. Joseph's University.
Kensey Nash Corporation (Nasdaq: KNSY) is a medical device company focusing on developing innovative products in cardiology, sports medicine, spine and orthopedics. The company developed, the market leading Angio-Seal vascular closure device which is licensed to St. Jude Medical. The company also has an extensive product portfolio of absorbable biomaterials used in cardiology, orthopedics, drug and biologics delivery, periodontal/dental and wound care markets. The Company's TriActiv Balloon Protected Flush Extraction System for the treatment of saphenous vein graft disease is available for sale in the European Union and is under 510(k) review in the United States. The TriActiv System is designed to prevent heart attacks during the treatment of saphenous vein grafts (SVGs) in patients who previously received coronary bypass surgery, but now have blockages in the grafts. The device incorporates three features to address the common problem of distal embolization - a protection balloon guidewire, a flush catheter, and an extraction system to remove debris from the grafts.
|
